Other proliferative retinopathy

H7_PROLIFRETINOPATHOTH

macular degeneration: Loss of vision in the central portion of the retina (macula), secondary to retinal degeneration. [ NCIT:P378 ]

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H35.20, H35.29
  • Hospital discharge: ICD-9 3622X
  • Cause of death: ICD-10 H35.20, H35.29
  • Cause of death: ICD-9 3622X

2 out of 7 registries used, show all original rules.

151

4. Check minimum number of events

None

151

5. Include endpoints

None

151

6. Filter based on genotype QC (FinnGen only)

151

Control definitions (FinnGen only)

Control exclude
H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1077 486 586
Only index persons 954 436 518
Unadjusted period prevalence (%)
Whole population 0.02 0.01 0.02
Only index persons 0.02 0.02 0.02
Median age at first event (years)
Whole population 57.82 60.71 55.52
Only index persons 57.13 59.71 54.95

-FinnGen-

Key figures

All Female Male
Number of individuals 151 71 80
Unadjusted period prevalence (%) 0.03 0.02 0.04
Median age at first event (years) 52.23 51.52 52.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
144
Matched controls
1439
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H35.29
ICD-10 Finland
Other proliferative retinopathy
+∞
100.0
84
*
H35.20
ICD-10 Finland
Proliferative vitreoretinopathy
+∞
67.0
59
*
CKC12
NOMESCO Finland
Photocoagulation of retina
819.3
57.9
53
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
268.2
54.0
52
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
+∞
48.8
44
*
H3603, E103
ICD-10 Finland
NA
+∞
48.8
44
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
30.2
47.8
66
39
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
+∞
47.6
43
*
XCK10
NOMESCO Finland
Photography of fundus of eye
26.8
46.5
67
45
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
84.0
46.1
50
9
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
167.0
45.9
46
*
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
111.3
44.0
46
6
A10AA02
ATC
NA
64.5
42.4
48
11
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
56.2
42.2
49
13
A10AA01
ATC
NA
117.2
40.3
42
5
XCW99
NOMESCO Finland
Other investigative procedure of eye
20.5
39.4
62
51
A10AE04
ATC
insulin glargine; parenteral
18.4
37.1
61
55
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
22.1
36.4
55
39
T89
ICPC
Diabetes insulin dependent
48.6
35.2
42
12
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
59.1
31.4
36
8
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
105.9
31.3
33
*
H36.01
ICD-10 Finland
Diabetic maculopathy
+∞
30.3
28
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
360.7
30.0
29
*
103
Kela drug reimbursment
Diabetes, insulin-treated
7.7
27.4
83
215
H3603, E113
ICD-10 Finland
NA
+∞
26.9
25
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
22.8
26.8
39
23
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
62.5
26.4
30
6
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
+∞
25.8
24
*
CKD40
NOMESCO Finland
Endophotocoagulation of retina
+∞
24.7
23
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
20.4
23.9
36
23
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
23.6
22
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
23.6
22
*
H04AA01
ATC
glucagon; nasal, parenteral
74.9
22.7
25
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
+∞
22.5
21
*
A10AE05
ATC
insulin detemir; parenteral
14.3
21.9
38
35
Z01.0
ICD-10 Finland
Examination of eyes and vision
8.3
21.8
54
97
CKC15
NOMESCO Finland
Panretinal photocoagulation
+∞
21.4
20
*
XCD20
NOMESCO Finland
Photoangiography of eye
+∞
21.4
20
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
+∞
21.4
20
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
16.1
20.7
34
27
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
+∞
20.3
19
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
6.2
20.2
67
178
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
5.3
19.5
85
308
H3601, E103
ICD-10 Finland
NA
+∞
19.2
18
*
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
42.8
18.2
22
6
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
72.3
17.2
19
*
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
+∞
17.0
16
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
102.2
17.0
18
*
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
178.6
15.8
16
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
4.6
15.5
68
233
Z96.1
ICD-10 Finland
Presence of intraocular lens
6.7
14.9
41
81
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
+∞
14.8
14
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
+∞
14.8
14
*
XCH00
NOMESCO Finland
Eye pressure measurement
18.3
14.5
22
14
S01ED51
ATC
timolol, combinations; ophthalmic
9.0
13.9
30
41
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
82.9
13.9
15
*
CKD20
NOMESCO Finland
Removal of vitreous body substitute
+∞
13.8
13
*
H34.8
ICD-10 Finland
Other retinal vascular occlusions
+∞
13.8
13
*
WX140
NOMESCO Finland
Parabulbar anesthesy
24.0
13.7
19
9
A10AE06
ATC
insulin degludec; parenteral
31.8
13.3
17
6
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
25.5
13.3
18
8
SPAT1262
SPAT
Handing over of treatment supplies
4.9
12.9
48
134
C03CA01
ATC
furosemide; systemic
4.0
12.7
64
239
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
+∞
12.7
12
*
H3600, E103
ICD-10 Finland
NA
+∞
12.7
12
*
H33.4
ICD-10 Finland
Traction detachment of retina
+∞
12.7
12
*
H3601, E113
ICD-10 Finland
NA
+∞
12.7
12
*
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
+∞
12.7
12
*
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
+∞
12.7
12
*
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
29.7
12.3
16
6
ZXA05
NOMESCO Finland
Left side
4.1
12.1
57
199
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
18.5
12.0
18
11
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
16.9
11.7
18
12
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
+∞
11.6
11
*
S01EC01
ATC
acetazolamide; systemic
19.1
11.5
17
10
C10AA01
ATC
simvastatin; oral
3.4
11.2
79
376
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
17.8
10.6
16
10
XCK00
NOMESCO Finland
Perimetry
7.5
10.6
25
39
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
118.3
10.6
11
*
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
118.3
10.6
11
*
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
10.5
10
*
ZXA10
NOMESCO Finland
Bilateral
4.5
10.5
41
118
A10AA03
ATC
NA
43.3
10.1
12
*
137
Kela drug reimbursment
Uraemia requiring dialysis
43.3
10.1
12
*
Z94.0
ICD-10 Finland
Kidney transplant status
43.3
10.1
12
*
C02AC05
ATC
moxonidine; oral
9.1
9.7
20
25
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
106.8
9.5
10
*
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
+∞
9.5
9
*
C09AA02
ATC
enalapril; systemic
3.7
9.3
45
156
J01FF01
ATC
clindamycin; systemic
3.3
9.2
56
232
E10
ICD-10 Finland
Type 1 diabetes mellitus
39.4
9.2
11
*
C10AA07
ATC
rosuvastatin; oral
3.5
8.9
50
192
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
9.2
8.9
18
22
177
Kela drug reimbursment
Insulin glargine 300 U / ml
21.6
8.6
12
6
C10AA05
ATC
atorvastatin; oral
3.0
8.5
64
303
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.9
8.5
71
358
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
95.4
8.5
9
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
95.4
8.5
9
*
205
Kela drug reimbursment
Chronic hypertension
3.2
8.4
54
229
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
+∞
8.4
8
*
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
+∞
8.4
8
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
+∞
8.4
8
*
CKD50
NOMESCO Finland
Endodiathermy of retina
+∞
8.4
8
*
H3600, E113
ICD-10 Finland
NA
+∞
8.4
8
*
CKC20
NOMESCO Finland
Cryopexy of undetached retina
+∞
8.4
8
*
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
+∞
8.4
8
*
H35.6
ICD-10 Finland
Retinal haemorrhage
+∞
8.4
8
*
127
Kela drug reimbursment
Transplant complication
15.7
8.4
13
9
A11CC03
ATC
alfacalcidol; systemic
12.8
7.7
13
11
S01ED01
ATC
timolol; ophthalmic
7.9
7.7
17
24
S01EX03
ATC
NA
19.7
7.7
11
6
N18.8
ICD-10 Finland
Other chronic renal failure
10.9
7.7
14
14
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.9
7.7
25
59
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
26.6
7.7
10
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
84.2
7.5
8
*
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
84.2
7.5
8
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.2
7.5
44
174
114
Kela drug reimbursment
Glaucoma
5.3
7.4
22
47
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
16.9
7.4
11
7
CKD15
NOMESCO Finland
Injection of vitreous substitute
+∞
7.3
7
*
H25.1
ICD-10 Finland
Senile nuclear cataract
3.0
7.3
48
203
Z49.1
ICD-10 Finland
Extracorporeal dialysis
31.8
7.2
9
*
S01EA03
ATC
apraclonidine; ophthalmic
31.8
7.2
9
*
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
31.8
7.2
9
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
31.8
7.2
9
*
L04AA06
ATC
mycophenolic acid; systemic
13.0
7.2
12
10
S01EE01
ATC
latanoprost; ophthalmic
7.0
7.2
17
27
A12AA04
ATC
calcium carbonate; oral
14.7
7.0
11
8
H26.02
ICD-10 Finland
Presenil cataract
10.1
6.9
13
14
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.9
6.9
22
51
T90
ICPC
Diabetes non-insulin dependent
3.1
6.9
41
162
B01AC04
ATC
clopidogrel; oral
3.7
6.9
31
100
B05DA
ATC
Isotonic solutions
42.1
6.8
8
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
23.8
6.8
9
*
ZXA00
NOMESCO Finland
Right side
2.8
6.6
50
229
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
8.0
6.6
14
19
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.7
6.6
18
35
NHQ40
NOMESCO Finland
Amputation of toe
15.2
6.5
10
7
S01FA04
ATC
cyclopentolate; ophthalmic
15.2
6.5
10
7
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
72.9
6.5
7
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
72.9
6.5
7
*
I10
ICD-10 Finland
Essential (primary) hypertension
2.5
6.3
89
572
RJ120
NOMESCO Finland
NA
+∞
6.3
6
*
H3603, E107
ICD-10 Finland
NA
+∞
6.3
6
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
+∞
6.3
6
*
H35.7
ICD-10 Finland
Separation of retinal layers
+∞
6.3
6
*
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
+∞
6.3
6
*
C09AA05
ATC
ramipril; oral
2.8
6.2
46
209
TK800
NOMESCO Finland
Hemodialysis
9.2
6.2
12
14
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
13.3
6.2
10
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
6.0
29
99

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
70
314
3.29
11.60
9.7
3.9
42.4
10.8
mg/mmol
2.05
58
205
67
294
3.30
11.50
8.2
3.1
239.7
67.1
mg/l
1.81
53
194
41
136
3.77
10.84
6.6
2.0
23.2
21.0
%
0.49
36
114
40
135
3.67
10.26
24.4
5.3
1.2
1.0
mmol/l
2.39
40
123
69
327
3.04
10.12
9.0
2.9
6.2
7.9
mmol/l
3.32
63
280
34
123
3.28
7.69
2.9
1.6
—
—
—
0
0
103
666
2.72
7.62
12.1
4.4
8.6
6.6
mmol/l
6.80
98
611
24
71
3.83
7.33
3.5
3.1
7.4
7.4
ph
—
5
8
12
20
6.43
7.02
3.1
1.2
—
—
—
0
0
63
344
2.43
6.38
8.3
3.0
16.4
229.6
e6/l
0.58
47
258
13
26
5.38
6.35
3.4
2.6
—
—
—
0
0
56
295
2.43
6.09
3.9
3.0
—
—
—
0
0
31
125
2.86
5.74
9.7
7.4
0.4
1.1
mmol/l
0.40
20
93
19
57
3.67
5.66
8.1
6.6
22.8
24.5
mmol/l
1.77
19
57
19
57
3.67
5.66
2.1
3.0
—
—
—
0
0
67
401
2.21
5.26
9.5
3.5
115.1
126.2
e6/l
0.04
50
275
5
0
+∞
5.23
3.2
0.0
2.2
—
mg/l
—
5
0
58
329
2.24
5.18
12.9
3.8
7.4
7.4
ph
—
9
61
9
9
10.54
5.10
2.0
2.6
—
—
—
0
0
9
9
10.54
5.10
1.1
1.6
—
—
—
0
0
47
247
2.31
5.01
1.5
1.2
1.8
2.3
u/ml
0.16
12
65
86
576
2.15
4.99
7.4
5.8
0.0
0.0
e9/l
0.82
78
516
87
589
2.13
4.87
7.5
5.8
1.9
1.9
e9/l
0.23
80
539
31
136
2.61
4.86
1.3
1.2
—
—
—
0
0
43
220
2.33
4.86
8.1
2.6
7.6
4.2
e6/l
0.95
38
195
10
20
5.28
4.85
3.0
3.4
—
—
—
0
0
85
575
2.09
4.72
7.0
5.7
0.6
0.6
e9/l
0.92
77
512
9
11
8.61
4.63
2.2
2.8
—
—
—
0
0
53
303
2.15
4.55
5.5
2.9
—
—
—
0
0
13
35
3.97
4.47
1.3
1.2
—
—
—
0
0
86
595
2.03
4.37
7.6
5.9
0.2
0.2
e9/l
1.39
78
536
22
86
2.82
4.28
16.5
8.3
—
—
—
0
0
72
471
2.01
4.25
13.5
4.3
34.5
36.1
g/l
1.71
67
441
28
126
2.50
4.15
26.1
22.1
1.6
1.2
inr
—
8
17
14
43
3.49
4.02
11.9
9.8
—
—
—
0
0
53
320
2.01
3.84
6.0
2.9
0.5
0.3
e6/l
0.59
33
230
59
372
1.96
3.77
4.9
3.0
2.3
2.3
mmol/l
1.83
59
329
38
204
2.15
3.75
6.1
3.0
111.6
86.0
ng/l
0.19
29
154
50
302
1.98
3.59
9.1
4.4
—
—
—
0
0
38
210
2.08
3.47
1.6
1.6
1367.6
1144.4
nmol/l
0.38
29
164
20
84
2.59
3.40
5.0
5.7
0.4
0.4
%
—
5
25
21
92
2.49
3.28
6.7
5.6
0.3
0.8
%
0.96
12
33
20
86
2.53
3.24
7.0
5.8
0.0
0.2
%
1.25
11
31
37
208
2.03
3.21
5.6
2.9
508.9
561.6
mosm/kgh2o
0.66
30
177
43
257
1.94
3.14
3.6
3.3
—
—
—
0
0
69
480
1.81
3.13
5.7
2.4
148.3
114.1
ug/l
1.01
64
435
90
680
1.80
3.07
11.1
9.2
4.1
4.1
e9/l
0.01
82
604
49
311
1.85
2.96
1.6
1.4
—
—
—
0
0
64
441
1.78
2.96
8.9
8.0
1.2
1.2
inr
0.13
21
134
19
85
2.41
2.84
6.1
2.5
—
—
—
0
0
41
249
1.89
2.83
1.6
1.8
1.2
1.3
mg/l
0.07
31
189
56
376
1.78
2.80
9.5
5.2
—
—
—
0
0
14
54
2.76
2.79
1.4
2.7
1.5
1.5
g/l
0.04
14
46
7
15
4.84
2.63
12.0
2.5
—
—
—
0
0
70
509
1.70
2.60
16.2
9.4
0.0
0.0
e9/l
0.08
54
420
53
358
1.74
2.56
3.6
2.3
—
—
—
0
0
75
560
1.67
2.49
5.2
3.6
0.0
0.0
estimate
0.00
11
102
7
17
4.26
2.39
2.1
1.6
—
—
—
0
0
21
107
2.12
2.34
12.9
3.7
—
—
—
0
0
75
567
1.64
2.33
5.5
3.6
0.0
0.0
estimate
—
10
99
6
13
4.76
2.29
1.0
1.5
—
—
—
0
0
60
433
1.64
2.22
1.9
1.8
97.0
92.5
pmol/l
0.44
33
218
43
285
1.71
2.18
7.5
3.3
91.3
91.0
%
0.02
43
278
8
25
3.32
2.12
3.0
2.5
112.5
125.3
g/l
—
8
15
27
158
1.86
2.06
4.8
2.0
—
—
—
0
0
73
561
1.58
2.04
7.3
4.9
0.0
0.0
estimate
0.00
11
105
12
51
2.47
2.00
2.8
3.1
—
—
—
0
0
15
72
2.20
1.94
3.1
1.9
456.3
271.3
ng/l
0.27
15
61
101
844
1.59
1.92
4.7
3.7
14.7
14.8
pmol/l
0.03
96
778
5
12
4.27
1.84
1.0
1.0
—
—
—
0
0
35
232
1.66
1.76
2.0
1.4
2.8
2.4
g/l
0.67
24
144
93
774
1.52
1.71
4.6
3.8
—
—
—
0
0
6
19
3.24
1.68
2.8
2.6
8.3
8.6
kpa
—
6
19
6
19
3.24
1.68
2.8
2.6
4.5
4.9
kpa
—
6
19
20
114
1.87
1.66
1.2
1.3
—
—
—
0
0
5
14
3.65
1.63
1.0
1.2
—
—
—
0
0
5
14
3.65
1.63
7.4
10.6
—
—
—
0
0
34
230
1.62
1.58
2.2
1.7
423.7
429.8
pmol/l
0.06
27
203
36
250
1.58
1.50
5.0
3.7
1.0
1.0
kg/l
—
5
29
93
788
1.47
1.47
8.3
4.2
—
—
—
0
0
36
253
1.56
1.42
5.6
5.1
—
—
—
0
0
39
280
1.53
1.40
2.3
1.6
1.6
1.4
mmol/l
0.33
34
235
6
23
2.67
1.38
3.0
1.7
—
—
—
0
0
12
62
2.02
1.32
2.1
3.6
3.9
4.5
pmol/l
1.46
12
51
109
963
1.47
1.31
35.7
16.8
13.9
13.7
%
0.69
104
944
25
164
1.63
1.31
2.8
1.6
—
—
—
0
0
58
459
1.43
1.28
5.2
4.0
1034.5
57.4
ng/l
0.52
47
305
41
307
1.46
1.20
6.1
3.7
0.0
0.0
estimate
—
10
99
22
143
1.63
1.20
1.6
1.4
—
—
—
0
0
13
72
1.88
1.19
4.6
4.1
—
—
—
0
0
5
20
2.55
1.16
1.2
2.5
—
—
—
0
0
24
161
1.58
1.16
1.4
1.4
413.3
516.6
titre
—
6
35
15
89
1.76
1.12
7.1
5.6
0.0
0.3
%
—
8
30
40
302
1.44
1.12
6.0
7.0
—
—
—
0
0
41
314
1.42
1.06
4.2
4.1
—
—
—
0
0
7
132
0.51
1.05
1.7
1.3
—
—
—
0
0
7
34
2.11
1.04
2.1
1.6
—
—
—
0
0
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
10
55
1.88
0.94
2.3
2.3
—
—
—
0
0
9
52
1.78
0.94
1.0
1.2
—
—
—
0
0
19
127
1.57
0.94
1.1
1.2
—
—
—
0
0
15
96
1.62
0.88
1.3
1.1
—
—
—
0
0
6
32
1.91
0.82
1.0
1.1
—
—
—
0
0
15
98
1.59
0.82
20.9
4.2
—
—
—
0
0
0
24
0.00
0.80
0.0
1.8
—
—
—
0
0
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
0
27
0.00
0.78
0.0
1.3
—
—
—
0
0
39
314
1.33
0.74
6.2
3.4
—
—
—
0
0
5
27
1.88
0.69
2.0
1.9
—
—
—
0
0
23
173
1.39
0.67
1.1
1.2
1.3
8.2
u/ml
—
10
74
15
104
1.49
0.65
1.3
1.3
—
—
—
0
0
16
113
1.47
0.64
3.9
2.3
12.4
14.4
nmol/l
0.65
16
106
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
125
1186
1.31
0.58
35.5
13.4
17.7
22.2
mg/l
1.48
107
922
8
121
0.64
0.57
1.1
1.4
—
—
—
0
0
9
59
1.56
0.56
2.9
4.2
—
—
—
0
0
113
1062
1.25
0.54
25.8
14.3
38.4
40.8
%
1.92
84
817
6
39
1.56
0.53
1.5
3.9
—
—
—
0
0
34
403
0.80
0.51
5.2
4.2
3.4
2.4
ug/l
0.26
34
365
25
201
1.29
0.49
2.9
1.6
—
—
—
0
0
7
49
1.45
0.46
3.0
4.9
—
—
—
0
0
9
130
0.67
0.45
1.0
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.49
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
12
89
1.38
0.39
9.2
3.6
—
—
—
0
0
12
89
1.38
0.39
3.4
3.1
—
—
—
0
0
14
107
1.34
0.39
1.6
1.5
—
—
—
0
0
5
36
1.40
0.38
1.2
1.2
—
—
—
0
0
9
117
0.75
0.28
2.0
1.6
—
—
—
0
0
8
67
1.20
0.27
1.1
1.2
—
—
—
0
0
9
73
1.25
0.26
1.1
1.3
—
—
—
0
0
128
1310
0.85
0.24
45.9
19.4
90.7
90.9
fl
0.26
128
1287
128
1310
0.85
0.24
45.8
19.4
30.2
30.3
pg
0.49
128
1287
0
10
0.00
0.21
0.0
3.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
216.2
—
0
10
0
12
0.00
0.21
0.0
3.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
47
437
1.11
0.19
2.5
2.0
—
—
—
0
0
38
404
0.92
0.13
4.9
2.8
—
—
—
0
0
21
230
0.90
0.12
2.7
2.8
1.2
0.8
ug/l
0.74
13
145
5
46
1.09
0.09
50.2
9.3
—
—
—
0
0
6
54
1.12
0.09
1.8
1.7
—
—
—
0
0
121
1226
0.93
0.08
29.0
12.6
—
—
—
0
0
8
90
0.88
0.07
1.4
1.4
—
—
—
0
0
26
249
1.05
0.04
2.9
1.9
—
—
—
0
0
11
117
0.94
0.02
1.8
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
1.1
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
9.9
—
0.7
—
0
7
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.9
—
10.9
—
0
9
0
6
0.00
0.00
0.0
2.8
—
5.9
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H7_PROLIFRETINOPATHOTH and mortality.

Females

Parameter HR [95% CI] p-value
H7_PROLIFRETINOPATHOTH 1.757 [1.36, 2.28] < 0.001
Birth year 0.995 [0.99, 1.0] 0.222

During the follow-up period (1.1.1998 — 31.12.2019), 134 out of 421 females with H7_PROLIFRETINOPATHOTH died.

Males

Parameter HR [95% CI] p-value
H7_PROLIFRETINOPATHOTH 1.773 [1.38, 2.27] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 161 out of 508 males with H7_PROLIFRETINOPATHOTH died.

Mortality risk

Mortality risk for people of age

years, who have H7_PROLIFRETINOPATHOTH.

N-year risk Females Males
1 0.143% 0.26%
5 0.924% 1.798%
10 2.162% 4.647%
15 4.478% 9.113%
20 8.041% 15.572%

Relationships between endpoints

Index endpoint: H7_PROLIFRETINOPATHOTH – Other proliferative retinopathy

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data